0

Liver Disease Collection
 101-120 of 966 Articles
Articles |  18 January 2000
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Stefano Bellentani, MD, PhD; Gioconda Saccoccio, MD; Flora Masutti, MD; et al.
Ann Intern Med. 2000;132(2):112-117. doi:10.7326/0003-4819-132-2-200001180-00004
Brief Communications |  18 January 2000
Hepatic Failure in a Patient Taking Rosiglitazone
Lisa M. Forman, MD; David A. Simmons, MD; Robert H. Diamond, MD
Ann Intern Med. 2000;132(2):118-121. doi:10.7326/0003-4819-132-2-200001180-00005
Brief Communications |  18 January 2000
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Jameela Al-Salman, MD; Heider Arjomand, MD; David G. Kemp, MD; et al.
Ann Intern Med. 2000;132(2):121-124. doi:10.7326/0003-4819-132-2-200001180-00006
Articles |  16 November 1999
Prophylactic Fluconazole in Liver Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled Trial
Drew J. Winston, MD; Anita Pakrasi, RN; Ronald W. Busuttil, MD, PhD
Ann Intern Med. 1999;131(10):729-737. doi:10.7326/0003-4819-131-10-199911160-00003
Brief Communications |  16 November 1999
Influence of the Vitamin D Receptor Gene Polymorphism on Bone Loss in Men after Liver Transplantation
Jordi Guardiola, MD; Xavier Xiol, MD; Richard Sallie, MD, FRACP; et al.
Ann Intern Med. 1999;131(10):752-755. doi:10.7326/0003-4819-131-10-199911160-00006
Brief Communications |  19 October 1999
Partial-Liver Transplantation To Treat Familial Amyloid Polyneuropathy: Follow-up of 11 Patients
Yo-ichi Takei, MD; Shu-ichi Ikeda, MD; Yasuhiko Hashikura, MD; et al.
Ann Intern Med. 1999;131(8):592-595. doi:10.7326/0003-4819-131-8-199910190-00008
Articles |  3 August 1999
Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan
Haruhiko Yoshida, MD; Yasushi Shiratori, MD; Mitsuhiko Moriyama, MD; et al.
Ann Intern Med. 1999;131(3):174-181. doi:10.7326/0003-4819-131-3-199908030-00003
Articles |  15 June 1999
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
Bruce R. Bacon, MD; John K. Olynyk, MD; Elizabeth M. Brunt, MD; et al.
Ann Intern Med. 1999;130(12):953-962. doi:10.7326/0003-4819-130-12-199906150-00002
Brief Communications |  16 February 1999
Nefazodone-Induced Liver Failure: Report of Three Cases
Jaime Aranda-Michel, MD; Alison Koehler, MD; Pablo A. Bejarano, MD; et al.
Ann Intern Med. 1999;130(4_Part_1):285-288. doi:10.7326/0003-4819-130-4-199902160-00013
Currents |  15 December 1998
Solid Organ Transplantation. 1: Many Problems, New Solutions
Paul Kefalides, MD
Ann Intern Med. 1998;129(12):1093-1095. doi:10.7326/0003-4819-129-12-199812150-00049
Diagnosis and Management |  1 December 1998
Diagnosis of Hemochromatosis
Lawrie W. Powell, MD; D. Keith George, MD; Sharon M. McDonnell, MD; et al.
Ann Intern Med. 1998;129(11_Part_2):925-931. doi:10.7326/0003-4819-129-11_Part_2-199812011-00002
Diagnosis and Management |  1 December 1998
Management of Hemochromatosis
James C. Barton, MD; Sharon M. McDonnell, MD, MPH; Paul C. Adams, MD; et al.
Ann Intern Med. 1998;129(11_Part_2):932-939. doi:10.7326/0003-4819-129-11_Part_2-199812011-00003
Population-Based Data |  1 December 1998
Prevalence of Elevated Serum Transferrin Saturation in Adults in the United States
Anne C. Looker, PhD; Clifford L. Johnson, MSPH
Ann Intern Med. 1998;129(11_Part_2):940-945. doi:10.7326/0003-4819-129-11_Part_2-199812011-00004
Population-Based Data |  1 December 1998
Hemochromatosis-Associated Mortality in the United States from 1979 to 1992: An Analysis of Multiple-Cause Mortality Data
Quanhe Yang, PhD; Sharon M. McDonnell, MD, MPH; Muin J. Khoury, MD, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):946-953. doi:10.7326/0003-4819-129-11_Part_2-199812011-00005
Screening |  1 December 1998
Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients
Pradyumna D. Phatak, MD; Ronald L. Sham, MD; Richard F. Raubertas, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):954-961. doi:10.7326/0003-4819-129-11_Part_2-199812011-00006
Screening |  1 December 1998
Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening
Mary E. Cogswell, DrPH; Sharon M. McDonnell, MD, MPH; Muin J. Khoury, MD, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):971-979. doi:10.7326/0003-4819-129-11_Part_2-199812011-00008
Brief Communications |  15 November 1998
Oral Thymic Extract for Chronic Hepatitis C in Patients Previously Treated with Interferon: A Randomized, Double-Blind, Placebo-Controlled Trial
Robert S. Raymond, MD; Michael B. Fallon, MD; Gary A. Abrams, MD
Ann Intern Med. 1998;129(10):797-800. doi:10.7326/0003-4819-129-10-199811150-00009
Reviews |  15 October 1998
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
Eytan Mor, MD; Ran Tur Kaspa, MD; Patricia Sheiner, MD; et al.
Ann Intern Med. 1998;129(8):643-653. doi:10.7326/0003-4819-129-8-199810150-00013
Brief Communications |  1 September 1998
Exhaled Nitric Oxide and Impaired Oxygenation in Cirrhotic Patients before and after Liver Transplantation
Giovanni Rolla, MD; Luisa Brussino, MD; Paola Colagrande, MD; et al.
Ann Intern Med. 1998;129(5):375-378. doi:10.7326/0003-4819-129-5-199809010-00005
Ideas and Opinions |  15 August 1998
Treating Histologically Mild Chronic Hepatitis C: Monotherapy, Combination Therapy, or Tincture of Time?
Robert A. Levine, MD
Ann Intern Med. 1998;129(4):323-326. doi:10.7326/0003-4819-129-4-199808150-00010
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)